All News

2019

July

Media Release / Jul 19, 2019

Novartis key multiple sclerosis product Gilenya® approved in China

Read More
Media Release / Jul 18, 2019

Novartis delivers strong sales, double digit core operating income growth and launches Zolgensma and Piqray in second quarter; sales and profit guidance increased

Read More
Media Release / Jul 16, 2019

FDA accepts file and accelerates review of Novartis sickle cell disease medicine crizanlizumab (SEG101)

Read More
Media Release / Jul 11, 2019

Novartis, Amgen and Banner Alzheimer's Institute discontinue clinical program with BACE inhibitor CNP520 for Alzheimer's prevention

Read More
Media Release / Jul 02, 2019

Sandoz launches oncology generic gefitinib in 13 EU countries at loss of market exclusivity, expanding access to essential medicine

Read More
Media Release / Jul 02, 2019

Novartis highlights cognition data in secondary progressive multiple sclerosis (SPMS)

Read More
Media Release / Jul 01, 2019

Novartis successfully completes acquisition of Xiidra®, bolstering ophthalmic portfolio

Read More
Media Release / Jul 01, 2019

Novartis data show Aimovig® cuts acute migraine medication days by half in patients who failed prior preventive therapies

Read More
Media Release / Jul 01, 2019

Novartis data underpin long-term efficacy of Aimovig® where other treatments have failed

Read More

June

Media Release / Jun 26, 2019

Novartis highlights new publication showing IL-17A antibody Cosentyx® improves inflammation and rapidly suppresses IL-23 in plaque psoriasis

Read More

Pages

Related Links

Novartis Annual Reporting Suite

Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society report.

Learn More